In the only study to assess differences in miRNA expression during insulin therapy in children with type 1 diabetes, 27 Australian adolescents without significant differences in baseline characteristics were randomized to CSII or MDI within 3 months of disease onset. Here, INS is linked to type 1 diabetes mellitus.